Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial.
作者信息
El Farissi Mohamed, Keulards Daniëlle C J, van 't Veer Marcel, Zelis Jo M, Berry Colin, De Bruyne Bernard, Engstrøm Thomas, Fröbert Ole, Piroth Zsolt, Oldroyd Keith G, Tonino Pim A L, Pijls Nico H J, Otterspoor Luuk C
机构信息
Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
出版信息
EuroIntervention. 2021 Apr 20;16(17):1444-1446. doi: 10.4244/EIJ-D-19-00471.
Abstract
摘要
相似文献
1
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial.ST段抬高型心肌梗死患者的选择性冠状动脉内低温治疗。EURO-ICE试验的原理与设计。
EuroIntervention. 2021 Apr 20;16(17):1444-1446. doi: 10.4244/EIJ-D-19-00471.
2
Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration.冠状动脉内与静脉内阿昔单抗在 ST 段抬高型心肌梗死中的应用：在接受血栓抽吸的直接经皮冠状动脉介入治疗的患者中进行 CICERO 试验的原理和设计。
Trials. 2009 Sep 28;10:90. doi: 10.1186/1745-6215-10-90.
3
Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.经皮冠状动脉介入治疗联合血栓抽吸术治疗 ST 段抬高型心肌梗死患者中冠状动脉内与静脉内应用阿昔单抗的比较：ST 段抬高型心肌梗死紧急再灌注时冠状动脉内与静脉内应用阿昔单抗的比较（CICERO）试验。
Circulation. 2010 Dec 21;122(25):2709-17. doi: 10.1161/CIRCULATIONAHA.110.002741. Epub 2010 Nov 15.
4
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中冠状动脉内注射与静脉推注阿昔单抗的比较：随机化的莱比锡直接经皮冠状动脉介入治疗ST段抬高型心肌梗死阿昔单抗静脉注射与冠状动脉内注射试验
Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16.
5
Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI.选择性冠状动脉内低温在急性前壁 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗中的安全性。
JACC Cardiovasc Interv. 2021 Sep 27;14(18):2047-2055. doi: 10.1016/j.jcin.2021.06.009. Epub 2021 Aug 25.
6
A pilot clinical study of adjunctive therapy with selective intracoronary hypothermia in patients with ST-segment elevation myocardial infarction.选择性冠状动脉内低温辅助治疗 ST 段抬高型心肌梗死患者的初步临床研究。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E433-E440. doi: 10.1002/ccd.27864. Epub 2018 Sep 28.
7
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的随机试验。
Lancet. 2012 Mar 10;379(9819):923-931. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21.
8
Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者冠状动脉内与静脉内推注阿昔单抗的比较：6 个月对梗死面积和左心室功能的影响。随机莱比锡即刻经皮冠状动脉介入阿昔单抗静脉内与冠状动脉内给药治疗 ST 段抬高型心肌梗死试验（LIPSIAbciximab-STEMI）。
Clin Res Cardiol. 2011 May;100(5):425-32. doi: 10.1007/s00392-010-0260-5. Epub 2010 Dec 2.
9
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.经皮冠状动脉介入治疗时冠状动脉内与静脉内推注阿昔单抗的比较：急性 ST 段抬高型心肌梗死中阿昔单抗冠状动脉内与静脉内药物应用（AIDA STEMI）试验的设计和原理。
Am Heart J. 2010 Apr;159(4):547-54. doi: 10.1016/j.ahj.2009.12.038.
10
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction.比较冠状动脉内注射与静脉注射阿昔单抗对急性ST段抬高型心肌梗死接受直接经皮冠状动脉血运重建术的吸烟者和非吸烟者疗效的汇总分析。
Am J Cardiol. 2016 Dec 15;118(12):1798-1804. doi: 10.1016/j.amjcard.2016.08.068. Epub 2016 Sep 13.
引用本文的文献
1
Molecular Mechanisms of Microvascular Obstruction and Dysfunction in Percutaneous Coronary Interventions: From Pathophysiology to Therapeutics-A Comprehensive Review.经皮冠状动脉介入治疗中微血管阻塞与功能障碍的分子机制：从病理生理学到治疗学——全面综述
Int J Mol Sci. 2025 Jul 16;26(14):6835. doi: 10.3390/ijms26146835.
2
SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI.SCAI关于接受直接PCI的ST段抬高型心肌梗死患者管理的专家共识声明。
J Soc Cardiovasc Angiogr Interv. 2024 Oct 7;3(11):102294. doi: 10.1016/j.jscai.2024.102294. eCollection 2024 Nov.
3
A randomised trial of selective intracoronary hypothermia during primary PCI.选择性冠状动脉内低温在直接经皮冠状动脉介入治疗中的随机试验。
EuroIntervention. 2024 Jun 17;20(12):e740-e749. doi: 10.4244/EIJ-D-23-01042.
4
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction.急性心肌梗死患者的冠状动脉微血管阻塞和功能障碍。
Nat Rev Cardiol. 2024 May;21(5):283-298. doi: 10.1038/s41569-023-00953-4. Epub 2023 Nov 24.
5
Cardioprotective Strategies After Ischemia-Reperfusion Injury.缺血再灌注损伤后的心脏保护策略。
Am J Cardiovasc Drugs. 2024 Jan;24(1):5-18. doi: 10.1007/s40256-023-00614-4. Epub 2023 Oct 10.
6
Device-Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies.基于器械的心肌梗伤心肌保护策略：创新策略的不断扩充。
J Am Heart Assoc. 2022 Dec 6;11(23):e026474. doi: 10.1161/JAHA.122.026474. Epub 2022 Nov 16.
7
"No-Reflow" Phenomenon: A Contemporary Review.“无复流”现象：当代综述
J Clin Med. 2022 Apr 16;11(8):2233. doi: 10.3390/jcm11082233.
8
Hypothermia for Cardioprotection in Patients with St-Elevation Myocardial Infarction: Do Not Give It the Cold Shoulder Yet!低温对ST段抬高型心肌梗死患者的心脏保护作用：仍不应忽视！
J Clin Med. 2022 Feb 18;11(4):1082. doi: 10.3390/jcm11041082.
9
New Interventional Therapies beyond Stenting to Treat ST-Segment Elevation Acute Myocardial Infarction.支架置入术之外治疗ST段抬高型急性心肌梗死的新型介入疗法
J Cardiovasc Dev Dis. 2021 Aug 24;8(9):100. doi: 10.3390/jcdd8090100.
10
Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials.急性心肌梗死患者的体温过低：随机试验的荟萃分析。
Clin Res Cardiol. 2021 Jan;110(1):84-92. doi: 10.1007/s00392-020-01652-7. Epub 2020 Apr 17.
本文引用的文献
1
Safety and feasibility of selective intracoronary hypothermia in acute myocardial infarction.选择性冠状动脉内低温治疗急性心肌梗死的安全性和可行性。
EuroIntervention. 2017 Dec 8;13(12):e1475-e1482. doi: 10.4244/EIJ-D-17-00240.
2
Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.直接经皮冠状动脉介入治疗后梗死面积与结局的关系：10 项随机试验的患者水平分析。
J Am Coll Cardiol. 2016 Apr 12;67(14):1674-83. doi: 10.1016/j.jacc.2016.01.069.
3
Myocardial reperfusion injury.心肌再灌注损伤
N Engl J Med. 2007 Sep 13;357(11):1121-35. doi: 10.1056/NEJMra071667.
4
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.急性心肌梗死的直接血管成形术与静脉溶栓治疗：23项随机试验的定量综述
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
5
Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction?轻度低温可减小跳动兔心脏的梗死面积：这是急性心肌梗死的一种实用干预措施吗？
Basic Res Cardiol. 1998 Oct;93(5):372-83. doi: 10.1007/s003950050105.
Zotero 插件